HOTH
Price
$0.79
Change
-$0.03 (-3.66%)
Updated
Dec 18, 04:57 PM (EDT)
PPTDF
Price
$17.15
Change
+$0.15 (+0.88%)
Updated
Dec 11 closing price
Ad is loading...

HOTH vs PPTDF

Header iconHOTH vs PPTDF Comparison
Open Charts HOTH vs PPTDFBanner chart's image
Hoth Therapeutics
Price$0.79
Change-$0.03 (-3.66%)
Volume$402
CapitalizationN/A
Peptidream
Price$17.15
Change+$0.15 (+0.88%)
Volume$2.05K
CapitalizationN/A
HOTH vs PPTDF Comparison Chart
Loading...
HOTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PPTDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HOTH vs. PPTDF commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HOTH is a Hold and PPTDF is a Buy.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (HOTH: $0.82 vs. PPTDF: $17.15)
Brand notoriety: HOTH and PPTDF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HOTH: 8% vs. PPTDF: 110%
Market capitalization -- HOTH: $5.66M vs. PPTDF: $2.18B
HOTH [@Biotechnology] is valued at $5.66M. PPTDF’s [@Biotechnology] market capitalization is $2.18B. The market cap for tickers in the [@Biotechnology] industry ranges from $482.1B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HOTH’s FA Score shows that 1 FA rating(s) are green whilePPTDF’s FA Score has 1 green FA rating(s).

  • HOTH’s FA Score: 1 green, 4 red.
  • PPTDF’s FA Score: 1 green, 4 red.
According to our system of comparison, PPTDF is a better buy in the long-term than HOTH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HOTH’s TA Score shows that 3 TA indicator(s) are bullish while PPTDF’s TA Score has 3 bullish TA indicator(s).

  • HOTH’s TA Score: 3 bullish, 5 bearish.
  • PPTDF’s TA Score: 3 bullish, 1 bearish.
According to our system of comparison, PPTDF is a better buy in the short-term than HOTH.

Price Growth

HOTH (@Biotechnology) experienced а -4.11% price change this week, while PPTDF (@Biotechnology) price change was +0.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.92%, and the average quarterly price growth was +0.65%.

Reported Earning Dates

HOTH is expected to report earnings on Mar 01, 2023.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PPTDF($2.18B) has a higher market cap than HOTH($5.66M). PPTDF YTD gains are higher at: 100.350 vs. HOTH (-43.063). PPTDF has higher annual earnings (EBITDA): 34.8B vs. HOTH (-7.53M). PPTDF has more cash in the bank: 25.5B vs. HOTH (8.02M). HOTH has less debt than PPTDF: HOTH (33.8K) vs PPTDF (20.9B). PPTDF has higher revenues than HOTH: PPTDF (55.4B) vs HOTH (0).
HOTHPPTDFHOTH / PPTDF
Capitalization5.66M2.18B0%
EBITDA-7.53M34.8B-0%
Gain YTD-43.063100.350-43%
P/E RatioN/A19.97-
Revenue055.4B-
Total Cash8.02M25.5B0%
Total Debt33.8K20.9B0%
FUNDAMENTALS RATINGS
HOTH vs PPTDF: Fundamental Ratings
HOTH
PPTDF
OUTLOOK RATING
1..100
3149
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
90
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9820
PRICE GROWTH RATING
1..100
7941
P/E GROWTH RATING
1..100
10098
SEASONALITY SCORE
1..100
9550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HOTH's Valuation (15) in the Pharmaceuticals Major industry is significantly better than the same rating for PPTDF (90) in the null industry. This means that HOTH’s stock grew significantly faster than PPTDF’s over the last 12 months.

HOTH's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as PPTDF (100) in the null industry. This means that HOTH’s stock grew similarly to PPTDF’s over the last 12 months.

PPTDF's SMR Rating (20) in the null industry is significantly better than the same rating for HOTH (98) in the Pharmaceuticals Major industry. This means that PPTDF’s stock grew significantly faster than HOTH’s over the last 12 months.

PPTDF's Price Growth Rating (41) in the null industry is somewhat better than the same rating for HOTH (79) in the Pharmaceuticals Major industry. This means that PPTDF’s stock grew somewhat faster than HOTH’s over the last 12 months.

PPTDF's P/E Growth Rating (98) in the null industry is in the same range as HOTH (100) in the Pharmaceuticals Major industry. This means that PPTDF’s stock grew similarly to HOTH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HOTHPPTDF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
38%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
35%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
33%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
36%
Advances
ODDS (%)
Bullish Trend 10 days ago
81%
N/A
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Ad is loading...
HOTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PPTDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BGAFX40.820.24
+0.59%
Baron Global Advantage Retail
JGIRX87.14-0.31
-0.35%
JPMorgan U.S. GARP Equity R5
REQTX51.74-0.25
-0.48%
Russell Inv Sustainable Equity S
FATEX120.12-0.76
-0.63%
Fidelity Advisor Technology M
FOVAX30.47-0.25
-0.81%
First Trust/Confluence Small Cap Val A

PPTDF and

Correlation & Price change

A.I.dvisor tells us that PPTDF and HOTH have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PPTDF and HOTH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PPTDF
1D Price
Change %
PPTDF100%
N/A
HOTH - PPTDF
31%
Poorly correlated
+1.22%
CYCC - PPTDF
28%
Poorly correlated
+7.11%
IGC - PPTDF
22%
Poorly correlated
+1.23%
LABFF - PPTDF
22%
Poorly correlated
N/A
CPMV - PPTDF
21%
Poorly correlated
N/A
More